XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1
STATEMENTS OF CASH FLOWS - USD ($)
7 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2023
Cash Flows from Operating Activities:    
Net loss $ (123,960) $ 2,911,033
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation expense 93,780 0
Interest and dividend income on investments held in Trust Account (13,351) (3,471,188)
Changes in operating assets and liabilities:    
Prepaid expenses (124,065) 108,438
Non-current prepaid expenses (19,716) 19,716
Accounts payable and accrued expenses 34,842 53,876
Net Cash Used in Operating Activities (152,470) (378,125)
Cash Flows from Investing Activities:    
Proceeds from sale and maturity of investments in Trust Account   78,147,387
Purchase of investments held in Trust Account (70,207,500) (72,122,203)
Monthly extension fee deposited into Trust Account   (280,000)
Net Cash Provided by (Used in) Investing Activities (70,207,500) 5,745,184
Cash Flows from Financing Activities:    
Proceeds from sale of public units through public offerings, net of underwriters' discount 67,620,000 0
Proceeds from sale of private placement units 3,857,500 0
Proceeds from issuance of promissory note to related party 389,200 0
Ordinary shares redemption   (5,925,184)
Repayment of promissory note to related party (389,200)  
Payment of offering costs (556,124)  
Proceeds from promissory notes   210,000
Proceeds form promissory notes - related party   70,000
Net Cash (Used in) Provided by Financing Activities 70,921,376 (5,645,184)
Net Change in Cash 561,406 (278,125)
Cash, beginning of period   561,406
Cash, end of year 561,406 283,281
Supplemental Disclosure of Cash Flow Information:    
Offering costs paid by Sponsor in exchange for issuance of ordinary shares 25,000 0
Deferred underwriting commission charged to additional paid in capital 2,415,000 0
Issuance of representative shares 1,046,000 0
Initial accretion of carrying value or public shares to redemption value (14,613,545) 0
Subsequent accretion of carrying value or public shares to redemption value (13,351) 0
Offering costs included in accrued expenses 0 45,000
Subsequent accretion of carrying value for public shares to redemption value $ 0 $ (3,651,188)